Cargando…

One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response

INTRODUCTION: Obesity is an increasingly common comorbidity in critically ill patients. Whether obesity alters sepsis outcome, susceptibility, treatment, and response is not completely understood. METHODS: We conducted a retrospective analysis comparing three group of septic shock patients based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Wacharasint, Petch, Boyd, John H, Russell, James A, Walley, Keith R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057102/
https://www.ncbi.nlm.nih.gov/pubmed/23786836
http://dx.doi.org/10.1186/cc12794
_version_ 1782320900543086592
author Wacharasint, Petch
Boyd, John H
Russell, James A
Walley, Keith R
author_facet Wacharasint, Petch
Boyd, John H
Russell, James A
Walley, Keith R
author_sort Wacharasint, Petch
collection PubMed
description INTRODUCTION: Obesity is an increasingly common comorbidity in critically ill patients. Whether obesity alters sepsis outcome, susceptibility, treatment, and response is not completely understood. METHODS: We conducted a retrospective analysis comparing three group of septic shock patients based on the intervals of actual body mass index (BMI) in patients enrolled in the VASST (Vasopressin and Septic Shock Trial) cohort. Primary outcome measurement was 28-day mortality. We tested for differences in patterns of infection by comparing the primary site of infection and organism. We also compared the treatments (fluids and vasopressors) and inflammatory response, measuring adipose tissue-related cytokine concentrations (interleukin [IL]-6, monocyte chemotactic protein [MCP]-1, tumor necrosis factor [TNF]-α, and resistin) in plasma in a subset of 382 patients. Of the 778 patients in VASST, 730 patients who had body weight and height measurements were analyzed. Patients with BMI <25 kg/m(2 )(n = 276) were grouped as a reference and compared to 'overweight' (25< BMI <30 kg/m(2), n = 209) and 'obese' (BMI >30 kg/m(2, )n = 245) patients. RESULTS: Obese patients had the lowest 28-day mortality followed by overweight patients while patients with BMI <25 kg/m(2 )had the highest mortality (p = 0.02). Compared to the patients with BMI <25 kg/m(2), obese and overweight patients also had a different pattern of infection with less lung (obese 35%, overweight 45%, BMI<25 kg/m(2 )50%, p = 0.003) and fungal infection (obese 8.2%, overweight 11%, and BMI<25 kg/m(2 )15.6%, p = 0.03). Per kilogram, obese and overweight patients received less fluid during the first four days (p<0.05) and received less norepinephrine (obese 0.14, overweight 0.21, BMI <25 kg/m(2 )0.26 µg/kg/min, p<0.0001) and vasopressin (obese 0.28, overweight 0.36, BMI <25 kg/m(2 )0.43 µU/kg/min, p<0.0001) on day 1 compared to patients with BMI <25 kg/m(2). Obese and overweight patients also had a lower plasma IL-6 concentration at baseline (obese 106 [IQR 34-686], overweight 190 [IQR 44-2339], BMI <25 kg/m(2 )235 [IQR 44-1793] pg/mL, p = 0.046). CONCLUSIONS: Overall obesity was associated with improved survival in septic shock and differences in pattern of infection, fluids, and vasopressors. Importantly, the magnitude of inflammatory IL-6 response is muted in the obese.
format Online
Article
Text
id pubmed-4057102
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40571022014-06-14 One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response Wacharasint, Petch Boyd, John H Russell, James A Walley, Keith R Crit Care Research INTRODUCTION: Obesity is an increasingly common comorbidity in critically ill patients. Whether obesity alters sepsis outcome, susceptibility, treatment, and response is not completely understood. METHODS: We conducted a retrospective analysis comparing three group of septic shock patients based on the intervals of actual body mass index (BMI) in patients enrolled in the VASST (Vasopressin and Septic Shock Trial) cohort. Primary outcome measurement was 28-day mortality. We tested for differences in patterns of infection by comparing the primary site of infection and organism. We also compared the treatments (fluids and vasopressors) and inflammatory response, measuring adipose tissue-related cytokine concentrations (interleukin [IL]-6, monocyte chemotactic protein [MCP]-1, tumor necrosis factor [TNF]-α, and resistin) in plasma in a subset of 382 patients. Of the 778 patients in VASST, 730 patients who had body weight and height measurements were analyzed. Patients with BMI <25 kg/m(2 )(n = 276) were grouped as a reference and compared to 'overweight' (25< BMI <30 kg/m(2), n = 209) and 'obese' (BMI >30 kg/m(2, )n = 245) patients. RESULTS: Obese patients had the lowest 28-day mortality followed by overweight patients while patients with BMI <25 kg/m(2 )had the highest mortality (p = 0.02). Compared to the patients with BMI <25 kg/m(2), obese and overweight patients also had a different pattern of infection with less lung (obese 35%, overweight 45%, BMI<25 kg/m(2 )50%, p = 0.003) and fungal infection (obese 8.2%, overweight 11%, and BMI<25 kg/m(2 )15.6%, p = 0.03). Per kilogram, obese and overweight patients received less fluid during the first four days (p<0.05) and received less norepinephrine (obese 0.14, overweight 0.21, BMI <25 kg/m(2 )0.26 µg/kg/min, p<0.0001) and vasopressin (obese 0.28, overweight 0.36, BMI <25 kg/m(2 )0.43 µU/kg/min, p<0.0001) on day 1 compared to patients with BMI <25 kg/m(2). Obese and overweight patients also had a lower plasma IL-6 concentration at baseline (obese 106 [IQR 34-686], overweight 190 [IQR 44-2339], BMI <25 kg/m(2 )235 [IQR 44-1793] pg/mL, p = 0.046). CONCLUSIONS: Overall obesity was associated with improved survival in septic shock and differences in pattern of infection, fluids, and vasopressors. Importantly, the magnitude of inflammatory IL-6 response is muted in the obese. BioMed Central 2013 2013-06-20 /pmc/articles/PMC4057102/ /pubmed/23786836 http://dx.doi.org/10.1186/cc12794 Text en Copyright © 2013 Wacharasint et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Wacharasint, Petch
Boyd, John H
Russell, James A
Walley, Keith R
One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response
title One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response
title_full One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response
title_fullStr One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response
title_full_unstemmed One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response
title_short One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response
title_sort one size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057102/
https://www.ncbi.nlm.nih.gov/pubmed/23786836
http://dx.doi.org/10.1186/cc12794
work_keys_str_mv AT wacharasintpetch onesizedoesnotfitallinsevereinfectionobesityaltersoutcomesusceptibilitytreatmentandinflammatoryresponse
AT boydjohnh onesizedoesnotfitallinsevereinfectionobesityaltersoutcomesusceptibilitytreatmentandinflammatoryresponse
AT russelljamesa onesizedoesnotfitallinsevereinfectionobesityaltersoutcomesusceptibilitytreatmentandinflammatoryresponse
AT walleykeithr onesizedoesnotfitallinsevereinfectionobesityaltersoutcomesusceptibilitytreatmentandinflammatoryresponse